Japan's Ono Pharma taps Texas startup Shattuck for $227M bifunctional fusion protein deal

Shattuck Labs’ pipeline of bifunctional fusion proteins has caught the attention of Ono Pharmaceutical, with the Japanese drug developer penning a $227 million biobucks deal focused on autoimmune and inflammatory diseases.